Patent Grant
10648133
The invention relates to compositions and methods for reducing excessive dusting during the manufacture of paper products.
Papermaking involves the preparation of a paper product from an aqueous suspension of cellulosic fibers by forming a mat of interwoven fibers and removal of water from the mat by various dewatering methods including free drainage, vacuum, pressing, and evaporative drying. A problem that is observed during the papermaking process and for the finished paper is the tendency for paper to release fiber and filler particles from the paper surface, leading to the formation of lint and dust. Excessive dusting can pose problems during the manufacture of tissue products, and can result in runnability and quality issues on papermaking machines. Moreover, dust and lint accumulation can create a fire hazard. In papermaking, there is also the potential for workers to be exposed to paper dust. Regular exposure to high levels of dust can affect the respiratory system and cause illness.
Tissue paper is a lightweight paper that can be used to prepare absorbent products such as bath tissue, facial tissue, and absorbent towels. Tissue paper is generally prepared by forming a wet web of wood pulp and transferring the web to a heated cylinder called a Yankee dryer to reduce the moisture content. The tissue paper is subjected to a creping process where the paper is scraped off of the Yankee Dryer by contacting a blade against the dryer. Creping makes the tissue sheets flexible, soft, and absorbent. Ideally, the resulting tissue should have high softness, while also having sufficient strength and resistance to dusting.
The creping process typically suffers from dusting issues, which occurs during contact of the creping blade with the tissue sheet. Loose dust particles are generated when mechanical force is applied to tissue paper, and is more pronounced in processes where tissue sheets are weak or loosely bonded. As generally observed in papermaking processes, the surface and fine fibers of the tissue are dispersed into air and settles on papermaking equipment. High dusting and linting tissue can create a nuisance for consumers with regard to cleanliness of the tissue/towel dispenser and surrounding areas.
A number of methods are used to reduce linting and dusting. Air jets as well as vacuum systems positioned near the papermaking process have been used to remove lint and dust released from the paper substrate, but these methods are generally energy inefficient and do not address dust generated by handling of the finished paper products.
Tissue dusting and linting remain a significant problem in the field and there continues to be a need for new strategies for dust reduction in tissue making.
In an embodiment, the invention provides a method for reducing dust in a tissue making process. The method comprises applying a polymer comprising at least one amine-containing vinylic or allylic monomer to the surface of a tissue web. In certain preferred embodiments, the polymer is applied to the surface of the tissue web prior to drying the tissue web.
In another embodiment, the invention provides a low dust tissue product. The tissue product comprises cellulosic fibers and a polymer comprising at least one amine-containing vinylic or allylic monomer. The polymer is disposed on at least one surface of the tissue product.
The following definitions are provided to determine how terms used in this application, and in particular, how the claims are to be construed. The organization of the definitions is for convenience only and is not intended to limit any of the definitions to any particular category.
“Acrylamide monomer” means a monomer of formula
wherein R1 is selected from the group consisting of H, C1-C16 alkyl, aryl, arylalkyl, C2-C16 alkenyl, C2-C16 alkynyl, heteroaryl, alkylheteroaryl, C3-C8 cycloalkyl, and halogen; and R2 is selected from the group consisting of hydrogen, C1-C16 alkyl, aryl, arylalkyl, C2-C16 alkenyl, C2-C16 alkynyl, heteroaryl, alkylheteroaryl, and hydroxyl;
“Aldehyde-functionalized polymer” refers to a polymer that results from a reaction between a polymer comprising at least one amide and/or amino group with an aldehyde. An “aldehyde” means a compound containing one or more aldehyde (—CHO) groups, where the aldehyde groups are capable of reacting with the amine group(s) of a polymer comprising an amine group as described herein. Representative aldehydes include formaldehyde, paraformaldehyde, glutaraldehyde, glyoxal, and the like;
“Amine-containing vinylic or allylic monomer” refers to compounds comprising both a nitrogen atom and a vinyl, allyl, or acrylic group. The amine-containing vinylic or allylic monomer generally comprises a primary or secondary amine. Nonlimiting examples include acrylamide compounds and diallylamine compounds;
“Paper” refers to sheet-like masses and molded products made from cellulosic materials which may be derived from natural sources as well as from synthetics. In addition, papers made from combinations of cellulosic and synthetic materials are applicable herein;
“Papermaking process” means a method of making paper and paperboard products from pulp comprising forming an aqueous cellulosic papermaking furnish (optionally, with mineral fillers, such as calcium carbonates, clays, etc.), draining the furnish to form a sheet, and drying the sheet. It should be appreciated that any suitable furnish may be used. Representative furnishes include, for example, virgin pulp, recycled pulp, kraft pulp (bleached and unbleached), sulfite pulp, mechanical pulp, polymeric plastic fibers, and the like, or any combination of the foregoing pulps. The steps of forming the papermaking furnish, draining and drying may be carried out in any manner generally known to those skilled in the art. In addition, other papermaking additives may be utilized in addition to the polymer treatment of this invention. Such papermaking additives include, for example, retention aids (e.g., microparticles, flocculants, polymeric and inorganic coagulants, etc.), wet and dry strength additives (e.g., cationic starches, polyamidoamine epichlorohydrin-based polymers), the like, and combinations thereof;
“Runnability” means the manner in which a sheet of paper or paper material passes trouble free through the stages and equipment in a papermaking process, as well as any subsequent converting processes such as folding, slitting, cutting, and plying. Complications which interrupt “runnability” include but are not limited to sheet breaks, jamming, clogging, fouling equipment, damaging equipment, and/or requiring more energy to pass the sheet of paper or paper precursor through the equipment;
“Surface strength” means the tendency of a paper substrate to resist damage due to abrasive force;
“Tissue paper” or “tissue product” refers to lightweight paper or an article comprising lightweight paper made using a papermaking process. Non-limiting examples of tissue paper or tissue product include toilet paper, paper towels, napkins, and facial tissues;
“Wet strength” means the tendency of a paper substrate to resist damage due to force(s) when rewet;
“Wet web consistency” refers to the percentage of dry fibers, by weight, in a paper web.
The invention provides methods for improving the dusting and strength properties of a paper product. The present invention is also directed to paper products having improved dusting and strength properties. The methods of the present invention include the application of a polymeric additive to the surface of the paper web during manufacture to produce paper that exhibits low dusting and increased strength. The polymeric additive comprises at least one amine-containing vinylic or allylic monomer. Applicants have surprisingly and unexpectedly discovered that when a polymer comprising an amine-containing vinylic or allylic monomer is applied to a paper web, the resulting paper product exhibits low dusting properties and has increased strength. Preferably, the polymeric additive is applied to at least one surface of the web, and in some embodiments, it is applied to both surfaces of the paper or tissue web. In particular, Applicants have discovered that paper products produced by the present methods exhibit lower lint and dust production when under mechanical stress and have greater wet and dry tensile strength than paper produced in the absence of a polymer comprising an amine-containing vinylic or allylic monomer. The present methods are useful for the manufacture of tissue products because tissue is quite susceptible to dusting and linting issues.
The methods of the present invention employ polymers comprising at least one amine-containing vinylic or allylic monomer, and have been found to improve the properties of a tissue web, and the resulting product. It has also been found that the polymeric additive improves the operation of a papermaking machine in some embodiments. In particular, the methods of the present invention produce tissue products that have a reduced tendency to produce dust. The methods of the present invention also reduce the amount of dust that accumulates on papermaking machinery. For example, a tissue making process employing the present methods has a reduced amount of dust accumulation at equipment such as the creping blade and the Yankee dryer.
Applicants have discovered that application of a polymer comprising at least one amine-containing vinylic or allylic monomer to a tissue web imparts beneficial properties to the resulting tissue sheet. Applicants have surprisingly and unexpectedly discovered that methods of the present invention can actually lead to an increase in tissue strength (e.g., wet and dry tensile strength). As a result, the present invention allows for the use of a lower amount of wet strength additive in the manufacture of tissue products. Without wishing to be bound by any particular theory, it is believed that application of a polymer comprising at least one amine-containing vinylic or allylic monomer to the surface of a tissue web reduces dusting by increasing the surface strength of the tissue.
In an embodiment, the invention provides a method for reducing dust in a tissue making process. The method comprises applying a polymer comprising at least one amine-containing vinylic or allylic monomer to the surface of a tissue web. In certain preferred embodiments, the polymer is applied to the surface of the tissue web prior to drying the tissue web.
The methods of the present invention comprise applying a polymer comprising at least one amine-containing vinylic or allylic monomer to a tissue web. The polymer is applied after formation of the tissue web. The methods of the present invention are in contrast to existing methods which incorporate low dusting additives into paper by adding the additive to paper stock, prior to web formation. For the present invention, the web is formed by depositing or spraying a suspension of papermaking fibers (e.g., aqueous suspension) onto a forming fabric or felt and the polymer is applied to the tissue web. The steps of forming the tissue making furnish (e.g., draining and drying) may be carried out in any manner generally known to those skilled in the art.
A polymer comprising at least one amine-containing vinylic or allylic monomer is applied to the surface of the tissue web using any suitable delivery method. In certain preferred embodiments, the polymer is sprayed onto the surface of the tissue web. In certain embodiments, the polymer is sprayed onto the surface of the tissue web using a spray boom. When a spray boom is used, a spray nozzle or multiple spray nozzles are used to spray the polymer onto the surface of the tissue web. In certain preferred embodiments, the polymer is fed through the spray boom at a rate of about 0.01 to about 0.5 gallons per minute. The polymer is disposed on the tissue web in any amount necessary to impart desired strength and dusting properties. The polymer can be applied to a portion of, or over the entire surface of, the tissue web.
The polymers of the present inventive methods are applied to the paper tissue in any form, including as a water-in-oil emulsion, dry powder, dispersion, or aqueous solution. In certain preferred embodiments, the polymer is applied to the surface of the tissue web as an aqueous solution. In certain preferred embodiments, a polymer comprising at least one amine-containing vinylic or allylic monomer is sprayed onto the surface of a tissue web. In certain preferred embodiments, an aqueous solution of a polymer comprising at least one amine-containing vinylic or allylic monomer is sprayed onto the surface of a tissue web. In certain embodiments, a polymer comprising at least one amine-containing vinylic or allylic monomer is dissolved in a water-soluble solvent and sprayed onto the surface of a tissue web.
The amount of polymer added to the paper web is not limited. In certain embodiments, a polymer comprising at least one amine-containing vinylic or allylic monomer is added to the tissue web in from about 0.05 kg to about 5 kg of dry polymer per ton of dry fiber. Thus, in certain embodiments, a polymer comprising at least one amine-containing vinylic or allylic monomer is added to the tissue web in from about 0.05 kg to about 5 kg of polymer per ton of dry fiber, from about 0.05 kg to about 4 kg of dry polymer per ton of dry fiber, from about 0.05 kg to about 3 kg of dry polymer per ton of dry fiber, from about 0.05 kg to about 2 kg of dry polymer per ton of dry fiber, from about 0.05 kg to about 1 kg of dry polymer per ton of dry fiber, from about 0.5 kg to about 5 kg of dry polymer per ton of dry fiber, or from about 1 kg to about 5 kg of dry polymer per ton of dry fiber. In certain preferred embodiments, a polymer comprising at least one amine-containing vinylic or allylic monomer is added to the tissue web in from about 0.05 kg to about 3 kg of dry polymer per ton of dry fiber.
The polymer can be applied to the surface of the tissue web as a solution having any suitable concentration. In certain embodiments, the polymer is applied to the tissue web as a solution having a concentration of polymer of from about 0.01% to about 10% by weight based on weight of the solution. In certain embodiments, the polymer is applied to the tissue web as a solution having a concentration of polymer of from about 0.01% to about 5% by weight based on weight of the solution.
In certain embodiments, a polymer comprising at least one amine-containing vinylic or allylic monomer is applied to a tissue web having a wet web consistency of from about 5% to about 90%. Thus, in certain embodiments, the polymer comprising at least one amine-containing vinylic or allylic monomer is applied to a tissue web having a wet web consistency of from about 5% to about 90%, from about 5% to about 80%, from about 5% to about 70%, from about 5% to about 60%, from about 5% to about 50%, from about 5% to about 40%, from about 5% to about 30%, from about 5% to about 20%, from about 10% to about 90%, from about 20% to about 90%, from about 30% to about 90%, from about 30% to about 80%, from about 30% to about 70%, from about 30% to about 60%, from about 30% to about 50%, from about 40% to about 90%, from about 40% to about 80%, or from about 40% to about 70%. In certain preferred embodiments, the polymer comprising at least one amine-containing vinylic or allylic monomer is applied to a tissue web having a wet web consistency of from about 5% to about 40%.
A polymer comprising an amine-containing vinylic or allylic monomer is applied to the surface of a tissue web. In certain preferred embodiments, the tissue sheet is creped, e.g., produced on a papermaking machine where a partially dried tissue web is adhered to and dried on a cylinder dryer (e.g., Yankee dryer) and removed by the action of a blade (e.g., creping blade). In certain preferred embodiments, the tissue web is treated with the polymer prior to heating with the drying cylinder (e.g., Yankee dryer) and prior to contact with the blade (e.g., creping blade). For example, the polymer can be applied at, e.g., felts, transfer fabrics, TAD fabrics, belts, and textured belts. In certain preferred embodiments, the tissue web is at least partially dried using a Yankee dryer after the polymer is applied to the tissue web.
Treatment of the tissue web with the polymer prior to contact with the creping blade reduces the amount of dusting that occurs during creping. In certain embodiments, a tissue web that has been surface treated with a polymer comprising at least one amine-containing vinylic or allylic monomer produces less dust at the creping blade as compared to tissue prepared in the absence of such surface treatment.
In certain embodiments, the composition and method of the present invention can be applied to tissue that is uncreped. In certain embodiments, uncreped webs may offer some advantages in surface smoothness as compared to creped paper webs.
The methods of the present invention provide tissue paper having increased strength. In certain embodiments, a method comprising applying a polymer comprising at least one amine-containing vinylic or allylic monomer to at least one surface of a tissue web produces tissue paper having greater wet and dry strength. In certain embodiments, applying a polymer comprising at least one amine-containing vinylic or allylic monomer to the surface of a tissue web provides tissue paper having greater wet strength (e.g., wet tensile) than paper produced in the absence of such surface treatment. In certain embodiments, applying a polymer comprising at least one amine-containing vinylic or allylic monomer to at least one surface of a tissue web provides tissue paper having greater dry strength (e.g., dry tensile) than paper produced in the absence of such surface treatment.
The amine-containing vinylic or allylic monomer is not limited, and can be non-ionic, cationic, anionic, and zwitterionic. In certain embodiments, the polymer used in the present inventive methods is a copolymer. In certain embodiments, the polymer used in the present inventive methods can comprise two or more monomeric species.
Representative non-ionic monomers include acrylamide, methacrylamide, N,N-dimethylacrylamide, N,N-diethylacrylamide, N-isopropylacrylamide, N-vinylformamide, N-vinylmethylacetamide, N-vinyl pyrrolidone, hydroxyethyl methacrylate, hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxypropyl methacrylate, N-t-butylacrylamide, N-methylolacrylamide, vinyl acetate, vinyl alcohol, similar monomers, and combinations thereof.
Representative anionic monomers include acrylic acid and its salts, including, but not limited to sodium acrylate and ammonium acrylate; methacrylic acid and its salts, including, but not limited to sodium methacrylate and ammonium methacrylate; 2-acrylamido-2-methylpropanesulfonic acid (“AMPS”); the sodium salt of AMPS; sodium vinyl sulfonate; styrene sulfonate; maleic acid and its salts, including, but not limited to the sodium salt, the ammonium salt, sulfonate, itaconate, sulfopropyl acrylate or methacrylate or other water-soluble forms of these or other polymerizable carboxylic or sulfonic acids; sulfomethylated acrylamide; allyl sulfonate; sodium vinyl sulfonate; itaconic acid; acrylamidomethylbutanoic acid; fumaric acid; vinylphosphonic acid; vinylsulfonic acid; allylphosphonic acid; sulfomethylated acrylamide; phosphonomethylated acrylamide; itaconic anhydride; similar monomers, and combinations thereof.
Representative cationic monomers or mer units of the primary or secondary amine include dialkylaminoalkyl acrylates and methacrylates and their quaternary or acid salts, including, but not limited to, dimethylaminoethyl acrylate methyl chloride quaternary salt (“DMAEA⋅MCQ”), dimethylaminoethyl acrylate methyl sulfate quaternary salt, dimethyaminoethyl acrylate benzyl chloride quaternary salt, dimethylaminoethyl acrylate sulfuric acid salt, dimethylaminoethyl acrylate hydrochloric acid salt, dimethylaminoethyl methacrylate methyl chloride quaternary salt, dimethylaminoethyl methacrylate methyl sulfate quaternary salt, dimethylaminoethyl methacrylate benzyl chloride quaternary salt, dimethylaminoethyl methacrylate sulfuric acid salt, dimethylaminoethyl methacrylate hydrochloric acid salt, dialkylaminoalkylacrylamides or methacrylamides and their quaternary or acid salts such as acrylamidopropyltrimethylammonium chloride, dimethylaminopropyl acrylamide methyl sulfate quaternary salt, dimethylaminopropyl acrylamide sulfuric acid salt, dimethylaminopropyl acrylamide hydrochloric acid salt, methacrylamidopropyltrimethylammonium chloride, dimethylaminopropyl methacrylamide methyl sulfate quaternary salt, dimethylaminopropyl methacrylamide sulfuric acid salt, dimethylaminopropyl methacrylamide hydrochloric acid salt, diethylaminoethylacrylate, diethylaminoethylmethacrylate, diallyldiethylammonium chloride and diallyldimethyl ammonium chloride (“DADMAC”), similar monomers, and combinations thereof.
Representative zwitterionic monomers include N,N-dimethyl-N-acryloyloxyethyl-N-(3-sulfopropyl)-ammonium betaine; N,N-dimethyl-N-acrylamidopropyl-N-(2-carboxymethyl)-ammonium betaine; N,N-dimethyl-N-acrylamidopropyl-N-(3-sulfopropyl)-ammonium betaine; N,N-dimethyl-N-acrylamidopropyl-N-(2-carboxymethyl)-ammonium betaine; 2-(methylthio)ethyl methacryloyl-S-(sulfopropyl)-sulfonium betaine; 2-[(2-acryloylethyl)dimethylammonio]ethyl 2-methyl phosphate; 2-(acryloyloxyethyl)-2′-(trimethylammonium)ethyl phosphate; [(2-acryloylethyl)dimethylammonio]methyl phosphonic acid; 2-methacryloyloxyethyl phosphorylcholine (“MPC”); 2-[(3-acrylamidopropyl)dimethylammonio]ethyl 2′-isopropyl phosphate (“AAPI”); 1-vinyl-3-(3-sulfopropyl)imidazolium hydroxide; (2-acryloxyethyl) carboxymethyl methylsulfonium chloride; 1-(3-sulfopropyl)-2-vinylpyridinium betaine; N-(4-sulfobutyl)-N-methyl-N, N-diallylamine ammonium betaine (“MDABS”); N,N-diallyl-N-methyl-N-(2-sulfoethyl) ammonium betaine; similar monomers, and combinations thereof.
In certain preferred embodiments, the polymer comprises an acrylamide monomer. In certain preferred embodiments, the acrylamide monomer is acrylamide, methacrylamide, N,N-dimethylacrylamide, N,N-diethylacrylamide, N-isopropylacrylamide, N-vinylformamide, N-vinylmethylacetamide, N-vinyl pyrrolidone, N-t-butylacrylamide, N-methylolacrylamide, and combinations thereof. In certain preferred embodiments, the acrylamide monomer is acrylamide.
It should be understood that a polymer in accordance with the present method may include at least one amine-containing vinylic or allylic monomer. In certain preferred embodiments, the polymer is a copolymer formed from a diallylamine monomer and an acrylamide monomer. In certain embodiments, the polymer may consist of diallylamine monomer and acrylamide monomer.
In certain embodiments, the polymer of the present inventive method is a copolymer. In certain preferred embodiments, the polymer is a diallylamine acrylamide copolymer. In certain embodiments, the copolymer comprises at least one diallylamine monomer and at least one acrylamide monomer. In certain preferred embodiments, the polymer comprises diallylamine monomer in an amount of from about 0.01 mol % to about 20 mol %. Thus, in certain embodiments, the polymer comprises diallylamine monomer in an amount of from about 0.01 mol % to about 20 mol %, from about 0.01 mol % to about 15 mol %, from about 0.01 mol % to about 10 mol %, or from about 0.01 mol % to about 5 mol %. In certain preferred embodiments, the polymer comprises acrylamide monomer in an amount of from about 0.01 mol % to about 85 mol %. Thus, in certain embodiments, the polymer comprises acrylamide monomer in an amount of from about 0.01 mol % to about 85 mol %, from about 0.01 mol % to about 80 mol %, from about 0.01 mol % to about 70 mol %, from about 0.01 mol % to about 60 mol %, from about 0.01 mol % to about 50 mol %, or from about 0.01 mol % to about 40 mol %. In certain embodiments, the polymer is a diallylamine acrylamide copolymer comprising from about 1 mol % to about 99 mol % diallylamine monomer. In certain embodiments, the diallylamine acrylamide copolymer comprises diallylamine monomers in an amount greater than acrylamide monomers (e.g., about 60 mol % to about 100 mol % diallylamine monomers). In certain embodiments, the diallylamine acrylamide copolymer comprises from about 10 mol % to about 60 mol % diallylamine monomer. In certain embodiments, the diallylamine acrylamide copolymer comprises about 10 mol % to about 40 mol % diallylamine monomer. In certain embodiments, the diallylamine acrylamide copolymer comprises about 0.1 mol % to about 20 mol % diallylamine monomer.
In certain embodiments, the polymer is a copolymer that comprises an amine-containing allylic monomer and at least one of dimethylaminoethylmethacrylate (DMAEM), dimethylaminoethylacrylate (DMAEA), diethylaminoethyl acrylate (DEAEA), or diethylaminoethyl methacrylate (DEAEM). In certain embodiments, the polymer is a copolymer comprising at least one diallyldimethyl-ammonium chloride monomer (DADMAC).
In certain embodiments, the polymer used in the present methods is a homopolymer. In certain embodiments, the homopolymer is an amine-containing allylic monomer. In certain preferred embodiments, the homopolymer is a diallylamine homopolymer.
In certain embodiments, the polymer is a mixture of polymers comprising at least one amine-containing vinylic or allylic monomer. In certain embodiments, the polymer is a polymer mixture comprising a diallylamine homopolymer. In certain embodiments, the polymer is a polymer mixture comprising a diallylamine acrylamide copolymer. In certain preferred embodiments, the polymer is a mixture of a diallylamine homopolymer and a diallylamine acrylamide copolymer.
The polymer comprising an amine-containing vinylic or allylic monomer can be prepared by any suitable method known in the art. In certain embodiments, the polymer is synthesized using water-in-oil polymerization, dispersion polymerization, gel polymerization, solution polymerization method, or a combination thereof.
In certain embodiments, the polymer comprising at least one amine-containing vinylic or allylic monomer is functionalized with an aldehyde. In certain embodiments, the aldehyde-functionalized polymer is formed by reacting a polymer comprising an amine-containing vinylic or allylic monomer with an aldehyde. In certain embodiments, the aldehyde used to form the aldehyde-functionalized polymer is selected from formaldehyde, paraformaldehyde, glutaraldehyde, glyoxal, and combinations thereof. In certain preferred embodiments, the aldehyde-containing polymer is a glyoxalated polyacrylamide polymer. In certain embodiments, the polymer used in the present inventive methods does not comprise an aldehyde-functionalized polymer.
The polymer used in the present methods can be of any suitable molecular weight. In certain embodiments, the polymer has an average molecular weight of from about 10,000 Daltons to about 5,000,000 Daltons. Thus, in certain embodiments, the polymer has an average molecular weight of from about 10,000 Daltons to about 5,000,000 Daltons, from about 10,000 Daltons to about 4,000,000 Daltons, from about 10,000 Daltons to about 3,000,000 Daltons, from about 10,000 Daltons to about 2,000,000 Daltons, from about 10,000 Daltons to about 1,500,000 Daltons, from about 10,000 Daltons to about 1,000,000 Daltons, from about 10,000 Daltons to about 500,000 Daltons, from about 10,000 Daltons to about 400,000 Daltons, from about 10,000 Daltons to about 300,000 Daltons, from about 10,000 Daltons to about 200,000 Daltons, from about 10,000 Daltons to about 100,000 Daltons, from about 10,000 Daltons to about 50,000 Daltons, from about 100,000 Daltons to about 2,000,000 Daltons, from about 100,000 Daltons to about 1,500,000 Daltons, from about 100,000 Daltons to about 1,000,000 Daltons, from about 100,000 Daltons to about 500,000 Daltons, from about 200,000 Daltons to about 1,500,000 Daltons, from about 200,000 Daltons to about 1,000,000 Daltons, or from about 400,000 Daltons to about 1,250,000 Daltons. In certain preferred embodiments, the polymer has an average molecular weight of from about 200,000 Daltons to about 1,750,000 Daltons. In certain preferred embodiments, the polymer has an average molecular weight of from about 400,000 Daltons to about 1,500,000 Daltons. In certain preferred embodiments, the polymer has an average molecular weight of from about 400,000 Daltons to about 800,000 Daltons. In certain preferred embodiments, the polymer has an average molecular weight of from about 1,000,000 Daltons to about 1,750,000 Daltons. In certain embodiments, the polymer is highly charged (e.g., comprises about 20% or more amine-containing allylic monomer) and has an average molecular weight of from about 400,000 Daltons to about 800,000 Daltons. In certain embodiments, the polymer has a low charge (e.g., comprises about 0.01% to about 20% amine-containing allylic monomer) and has an average molecular weight of from about 800,000 Daltons to about 1,750,000 Daltons.
In certain embodiments, the papermaking methods of the present invention may optionally include one or more materials that are cationic in nature or capable of ionizing or dissociating in such a manner as to produce one or more cations or other positively charged moieties. Such cationic agents have been found useful as a means for aiding in the retention of fiber, fines, and filler in paper, and those of skill in the art commonly refer to these as retention agents, aids, packages, and the like. Other cationic agents include, for example, cationic starch derivatives, including primary, secondary, tertiary, or quaternary amine starch derivatives and other cationic nitrogen substituted starch derivatives. Such derivatives may be prepared from all types of starches including corn, tapioca, potato, waxy maize, wheat, and rice. Moreover, they may be in their original granule form or they may be converted to pre-gelatinized, cold water soluble products and/or employed in liquid form. In certain embodiments, the papermaking methods of the present invention may include flocculants, coagulants, microparticles, or combinations thereof.
Other additives may be used in conjunction with the present invention. Additional agents include wet strength aids, dry strength aids, debonding agents, softening agents, adhesive chemicals, sizing agents, dyes, optical brighteners, absorbency aids, and the like. Other additives include odor control materials and deodorants, pigments, humectants, emollients, bactericides, buffers, waxes, zeolites, lotions, perfumes, vegetable and mineral oils, superabsorbents, surfactants, fungicides, moisturizers, and the like.
The wood pulp source used to produce the papermaking fibers is not limited. For example, hardwood and softwood pulps and a combination thereof can be used as a source of papermaking fibers for the tissue webs of the present invention. Useful wood pulps include chemical pulps such as sulfite and sulfate pulps (e.g., Kraft pulp) as well as mechanical pulps including ground wood, ThermoMechanical Pulp, and Chemi-ThermoMechanical Pulp. Papermaking fibers derived from recycled paper can also be used with the present invention. In certain embodiments, the papermaking fibers are virgin chemical wood pulps.
In another embodiment, a low dust tissue product comprises cellulosic fibers and a polymer comprising at least one amine-containing vinylic or allylic monomer, where the polymer is disposed on at least one surface of the tissue product.
The polymer in the low dust tissue product is the same as the polymer applied to the tissue web, as described above. By way of example, and not in limitation, in certain embodiments, the polymer comprises an acrylamide monomer. In certain embodiments, the polymer comprises a diallylamine monomer. In certain embodiments, the polymer is a diallylamine homopolymer. In certain embodiments, the polymer is a mixture of diallylamine homopolymer and diallylamine acrylamide copolymer. In certain preferred embodiments, the polymer is a diallylamine acrylamide copolymer. In certain embodiments, the diallylamine acrylamide copolymer comprises diallylamine monomer in an amount greater than acrylamide monomer. In certain embodiments, the diallylamine acrylamide copolymer comprises from about 10 to about 60 mole percent diallylamine monomer. In certain preferred embodiments, the diallylamine acrylamide copolymer comprises about 5 to about 40 mole percent diallylamine monomer.
In certain preferred embodiments, the tissue product is formed by applying the polymer to a surface of the tissue web. In certain embodiments, a polymer comprising at least one amine-containing vinylic or allylic monomer is added to the tissue web in from about 0.05 kg to about 5 kg of dry polymer per ton of tissue product. Thus, in certain embodiments, a polymer comprising at least one amine-containing vinylic or allylic monomer is added to the tissue web in from about 0.05 kg to about 5 kg of dry polymer per ton of tissue product, from about 0.05 kg to about 4 kg of dry polymer per ton of tissue product, from about 0.05 kg to about 3 kg of dry polymer per ton of tissue product, from about 0.05 kg to about 2 kg of dry polymer per ton of tissue product, from about 0.05 kg to about 1 kg of dry polymer per ton of tissue product, from about 0.5 kg to about 5 kg of dry polymer per ton of tissue product, or from about 1 kg to about 5 kg of dry polymer per ton of tissue product. In certain preferred embodiments, a polymer comprising at least one amine-containing vinylic or allylic monomer is added to the tissue web in from about 0.05 kg to about 3 kg of dry polymer per ton of tissue product.
In certain embodiments, the tissue product comprises a tissue sheet having a weight of from about 5 g/m2 to about 40 g/m2. In certain embodiments, the tissue product comprises a tissue sheet having a weight of from about 5 g/m2 to about 20 g/m2. In certain embodiments, the tissue product comprises a tissue sheet having a weight of from about 10 g/m2 to about 30 g/m2.
In certain embodiments, the polymer comprising at least one amine-containing vinylic or allylic monomer is disposed on two surfaces of the tissue product.
The tissue product of the present invention is single-layered or multi-layered. The tissue product can be a single-ply tissue paper in which the web forming the tissue is stratified, i.e., has multiple layers, or a multi-ply tissue product in which the webs forming the multi-ply tissue product may be either single or multi-layered. It should be understood that the tissue paper can include any number of plies or layers. In certain embodiments, a polymer comprising an amine-containing vinylic or allylic monomer is applied to the top layer of the tissue, or to the layer that will ultimately become the top layer of the tissue. In certain embodiments, the polymer may also be applied to the outer layer of a multi-layer tissue.
The tissue product can be any article which comprises tissue paper. In certain embodiments, the tissue product is bathroom tissue, facial tissue, napkin, or an absorbent towel (e.g., paper towels).
The following examples further illustrate the invention but, of course, should not be construed as in any way limiting its scope.
This Example illustrates dust generated from tissue produced using a method in accordance with an embodiment of the invention.
A 17.6 g/m2 premium facial tissue sheet on a crescent former tissue making machine was treated with a diallylamine acrylamide copolymer by spraying the polymer on the surface of the tissue web. The tissue web was formed from a fiber stock slurry having a consistency of 0.08%. The web had a two-layer construction consisting of a 55/45 (wt/wt) fiber split. The fiber in the 55 wt % layer consisted of 100% Eucalyptus fibers and the fiber in the 45 wt % layer consisted of 90% softwood and 10% machine broke. The diallylamine acrylamide copolymer was prepared by mixing the polymer with water to obtain an aqueous solution having a concentration of 0.5% (V/V). The diallylamine acrylamide had a molecular weight of about 1,000,000 Daltons and consisted of 15 mol % diallylamine and 85 mol % acrylamide (equivalent to a charge density of about 2 meq/g). The diallylamine acrylamide solution was fed through the spray boom at an application rate of 0.38 pound of dry product to dry ton of fiber in the tissue web. The diallylamine acrylamide polymer solution was sprayed on the sheet side of the felt (Eucalyptus layer), just after the sheet transfer roll. The web consistency at this point in the process is approximately 10% and the web speed was 884 m/min. The apparatus for applying the dust reduction agent was a spray boom consisting of a 1 inch diameter pipe having a total length of 198 inches. Twenty-one spray nozzles were spaced 8 inches apart along the pipe to apply the diallylamine acrylamide copolymer over the 169 inch width of the tissue sheet. The nozzle spray angles were 110 degrees and each delivered 0.1 gallons per minute at the 40 psi boom pressure. The tissue sheet was dried using a Yankee dryer and subjected to a creping process using a flexible creping blade. The tissue sheet moisture at the finished reel was 4.4%. For each sample, dust was collected for a time period of one hour by placing a 9 inch×13 inch pan underneath the creping blade. The amount of dusting at the creping blade was measured gravimetrically. The collected dust was weighed and recorded.
The anti-dusting effect of applying diallylamine acrylamide copolymer to the surface of a tissue web was evaluated through paper machine trials. The amount of dust collected at the creping blade during the trial is shown at
This Example illustrates the dusting and strength properties of a tissue sheet produced using a method in accordance with an embodiment of the invention.
A 17.6 g/m2 premium facial tissue sheet on a crescent former tissue making machine was treated with a diallylamine acrylamide copolymer and subjected to creping in the same manner as the tissue sheet of Example 1. The diallylamine acrylamide copolymer was the same as the copolymer used in Example 1. After the tissue sheet was sprayed with diallylamine acrylamide copolymer, the dust generated during the creping process was measured as done in Example 1. The amount of wet strength additive added to the furnish was also recorded. In addition, the dry and wet tensile strength of the tissue was measured. Dry and wet tensile tests were conducted in a conditioned temperature and humidity room in general accordance with TAPPI standards (e.g., T450 om-03, T494 om-06, and T576 pm-07). The tissue test specimens were 1 inch wide. For wet tensile tests, the strips were wetted in the middle of the span with a brush.
The effect of applying a diallylamine acrylamide copolymer to a tissue web on dusting, wet strength additive dosage, and tensile strength was evaluated through a paper machine trial shown in
The effect of application of a diallylamine acrylamide copolymer to a tissue web on wet strength additive dosage in a tissue making process was also evaluated during the same trial.
The effect of application of a diallylamine acrylamide copolymer to a tissue web on wet tensile strength and dry tensile strength was evaluated as shown in
Table 1 shows that the wet and dry tensile strength of the tissue increased with addition of diallylamine acrylamide copolymer to the tissue web in accordance with an embodiment of the invention. As shown in Table 1, the MD dry strength was 408 g/in prior to adding diallylamine acrylamide copolymer to the tissue web (see Pre-trial data). After application of the diallylamine acrylamide copolymer to the tissue web, the MD dry tensile strength increased to 463 Win (see Trial data). Similarly, CD dry tensile strength and CD wet tensile strength increased when the tissue web was treated with diallylamine acrylamide copolymer. The data of
The use of the terms “a” and “an” and “the” and “at least one” and similar referents in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The use of the term “at least one” followed by a list of one or more items (for example, “at least one of A and B”) is to be construed to mean one item selected from the listed items (A or B) or any combination of two or more of the listed items (A and B), unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
This application is a nonprovisional application claiming the benefit of U.S. Provisional Patent Application No. 62/336,236, filed May 13, 2016, the disclosure of which is incorporated by reference herein in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2059465 | Kress | Nov 1936 | A |
| 2601597 | Daniel, Jr. et al. | Jun 1952 | A |
| 2765229 | McLaughlin | Oct 1956 | A |
| 2982749 | Friedrich et al. | May 1961 | A |
| 3102064 | Wurzburg et al. | Aug 1963 | A |
| 3233962 | Nelson | Feb 1966 | A |
| 3234076 | Goldsmith | Feb 1966 | A |
| 3284393 | Vanderhoff et al. | Nov 1966 | A |
| 3409500 | Strazdins et al. | Nov 1968 | A |
| 3507847 | Coscia | Apr 1970 | A |
| 3555932 | Schwerdhöfer | Jan 1971 | A |
| 3556932 | Coscia et al. | Jan 1971 | A |
| 3734873 | Anderson et al. | May 1973 | A |
| 3772076 | Keim | Nov 1973 | A |
| 3821069 | Wurzburg | Jun 1974 | A |
| RE28474 | Anderson et al. | Jul 1975 | E |
| RE28576 | Anderson et al. | Oct 1975 | E |
| 3951921 | Espy | Apr 1976 | A |
| 3968005 | Wurzburg | Jul 1976 | A |
| 4040900 | Mazzarella et al. | Aug 1977 | A |
| 4210489 | Markofsky | Jul 1980 | A |
| 4493659 | Iwashita | Jan 1985 | A |
| 4533434 | Yoshioka et al. | Aug 1985 | A |
| 4603176 | Bjorkquist et al. | Jul 1986 | A |
| 4605702 | Guerro et al. | Aug 1986 | A |
| 4657946 | Rende et al. | Apr 1987 | A |
| 4915786 | Sweeney | Apr 1990 | A |
| 4919821 | Fong et al. | Apr 1990 | A |
| 4929655 | Takeda et al. | May 1990 | A |
| 4956399 | Kozakiewicz et al. | Sep 1990 | A |
| 5006590 | Takeda et al. | Apr 1991 | A |
| 5147908 | Floyd et al. | Sep 1992 | A |
| 5179150 | Furman, Jr. | Jan 1993 | A |
| 5187219 | Furman, Jr. | Feb 1993 | A |
| 5223092 | Grinnell | Jun 1993 | A |
| 5271806 | Deutsch | Dec 1993 | A |
| 5281307 | Smigo et al. | Jan 1994 | A |
| 5324792 | Ford | Jun 1994 | A |
| 5374334 | Sommese | Dec 1994 | A |
| 5438087 | Ikeda et al. | Aug 1995 | A |
| 5474856 | Tamagawa et al. | Dec 1995 | A |
| 5501774 | Burke | Mar 1996 | A |
| 5571380 | Fallon | Nov 1996 | A |
| 5597858 | Ramesh et al. | Jan 1997 | A |
| 5597859 | Hurlock et al. | Jan 1997 | A |
| 5605970 | Selvarajan | Feb 1997 | A |
| 5654198 | Carrier et al. | Aug 1997 | A |
| 5674362 | Underwood et al. | Oct 1997 | A |
| 5837776 | Selvarajan et al. | Nov 1998 | A |
| 5865951 | Kawakami et al. | Feb 1999 | A |
| 5938937 | Sparapany et al. | Aug 1999 | A |
| 5961782 | Luu et al. | Oct 1999 | A |
| 5985992 | Chen | Nov 1999 | A |
| 6013705 | Chen et al. | Jan 2000 | A |
| 6013708 | Mallon et al. | Jan 2000 | A |
| 6027611 | McFarland | Feb 2000 | A |
| 6077394 | Spence et al. | Jun 2000 | A |
| 6083348 | Auhorn et al. | Jul 2000 | A |
| 6153049 | Croft | Nov 2000 | A |
| 6190499 | Oriaran et al. | Feb 2001 | B1 |
| 6238519 | Jones | May 2001 | B1 |
| 6238521 | Shing et al. | May 2001 | B1 |
| 6245874 | Staib et al. | Jun 2001 | B1 |
| 6315866 | Sanchez | Nov 2001 | B1 |
| 6348132 | Zhang et al. | Feb 2002 | B1 |
| 6426383 | Fong et al. | Jul 2002 | B1 |
| 6472487 | Schroeder et al. | Oct 2002 | B2 |
| 6491790 | Proverb et al. | Dec 2002 | B1 |
| 6592718 | Wong Shing et al. | Jul 2003 | B1 |
| 6610209 | Sommese et al. | Aug 2003 | B1 |
| 6699359 | Luu et al. | Mar 2004 | B1 |
| 6743335 | Proverb et al. | Jun 2004 | B2 |
| 6746542 | Lorencak et al. | Jun 2004 | B1 |
| 6787574 | Anderson et al. | Sep 2004 | B1 |
| 6808595 | Burns | Oct 2004 | B1 |
| 6815497 | Luu et al. | Nov 2004 | B1 |
| 6939443 | Ryan et al. | Sep 2005 | B2 |
| 7034087 | Hagiopol et al. | Apr 2006 | B2 |
| 7119148 | Hagiopol et al. | Oct 2006 | B2 |
| 7125469 | Barcus et al. | Oct 2006 | B2 |
| 7125695 | Schellenberger et al. | Oct 2006 | B2 |
| 7323510 | Fischer et al. | Jan 2008 | B2 |
| 7455751 | Ward et al. | Nov 2008 | B2 |
| 7488403 | Hagiopol et al. | Feb 2009 | B2 |
| 7550060 | Jacobson et al. | Jun 2009 | B2 |
| 7615135 | Harrington et al. | Nov 2009 | B2 |
| 7641766 | St. John et al. | Jan 2010 | B2 |
| 7641776 | Nagar et al. | Jan 2010 | B2 |
| 7683121 | Wei et al. | Mar 2010 | B2 |
| 7740743 | Singh et al. | Jun 2010 | B2 |
| 7794565 | Shannon et al. | Sep 2010 | B2 |
| 7863395 | Hagiopol et al. | Jan 2011 | B2 |
| 7897013 | Hagiopol et al. | Mar 2011 | B2 |
| 7914646 | Duggirala et al. | Mar 2011 | B2 |
| 7938934 | Todorovic et al. | May 2011 | B2 |
| 7972478 | Hund et al. | Jul 2011 | B2 |
| 8025924 | Ohira et al. | Sep 2011 | B2 |
| 8070914 | Ryan et al. | Dec 2011 | B2 |
| 8088213 | Cheng et al. | Jan 2012 | B2 |
| 8088250 | Cheng et al. | Jan 2012 | B2 |
| 8288502 | Bode et al. | Oct 2012 | B2 |
| 8349134 | Esser et al. | Jan 2013 | B2 |
| 8382947 | Skaggs et al. | Feb 2013 | B2 |
| 8404083 | Haehnle et al. | Mar 2013 | B2 |
| 8414739 | Kimura et al. | Apr 2013 | B2 |
| 8425724 | Ryan et al. | Apr 2013 | B2 |
| 8444818 | Sutman et al. | May 2013 | B2 |
| 8454798 | Ban et al. | Jun 2013 | B2 |
| 8465623 | Zhao et al. | Jun 2013 | B2 |
| 8636875 | McKay | Jan 2014 | B2 |
| 8647472 | Cheng et al. | Feb 2014 | B2 |
| 8696869 | Borkar et al. | Apr 2014 | B2 |
| 8709207 | Grimm | Apr 2014 | B2 |
| 8709208 | Zhao et al. | Apr 2014 | B2 |
| RE44936 | St. John et al. | Jun 2014 | E |
| 8747617 | Cheng et al. | Jun 2014 | B2 |
| 8753480 | Bode et al. | Jun 2014 | B2 |
| 8840759 | Benz et al. | Sep 2014 | B2 |
| 8852400 | St. John | Oct 2014 | B2 |
| 8882964 | Zhao et al. | Nov 2014 | B2 |
| 8894817 | Cheng et al. | Nov 2014 | B1 |
| 8920606 | Wright | Dec 2014 | B2 |
| 8999111 | Castro et al. | Apr 2015 | B2 |
| 9011643 | Gu et al. | Apr 2015 | B2 |
| 9034145 | Castro et al. | May 2015 | B2 |
| 9051687 | Esser et al. | Jun 2015 | B2 |
| 9145646 | Benz et al. | Sep 2015 | B2 |
| 9328462 | Chen et al. | May 2016 | B2 |
| 9840810 | Castro | Dec 2017 | B2 |
| 20020045704 | Luu | Apr 2002 | A1 |
| 20020139500 | Runge | Oct 2002 | A1 |
| 20030056917 | Jimenez | Mar 2003 | A1 |
| 20030224945 | Twu et al. | Dec 2003 | A1 |
| 20040060677 | Huang | Apr 2004 | A1 |
| 20040084162 | Shannon | May 2004 | A1 |
| 20060142535 | Cyr et al. | Jun 2006 | A1 |
| 20060201645 | Ito | Sep 2006 | A1 |
| 20070000630 | Hassler et al. | Jan 2007 | A1 |
| 20080149287 | Hagiopol et al. | Jun 2008 | A1 |
| 20080196851 | Hund et al. | Aug 2008 | A1 |
| 20080277084 | Denowski et al. | Nov 2008 | A1 |
| 20080308242 | Lu et al. | Dec 2008 | A1 |
| 20090107644 | Cowman et al. | Apr 2009 | A1 |
| 20090145566 | Esser et al. | Jun 2009 | A1 |
| 20090165978 | Hagiopol et al. | Jul 2009 | A1 |
| 20090281212 | Pawlowska et al. | Nov 2009 | A1 |
| 20100018660 | Varnell | Jan 2010 | A1 |
| 20100193147 | Ryan et al. | Aug 2010 | A1 |
| 20110083821 | Wright | Apr 2011 | A1 |
| 20110132559 | Haehnle et al. | Jun 2011 | A1 |
| 20110146925 | Bode et al. | Jun 2011 | A1 |
| 20110155339 | Brungardt | Jun 2011 | A1 |
| 20120035306 | Ryan et al. | Feb 2012 | A1 |
| 20120073773 | Jehn-Rendu et al. | Mar 2012 | A1 |
| 20120073774 | Jehn-Rendu et al. | Mar 2012 | A1 |
| 20120103546 | Maniere | May 2012 | A1 |
| 20120103547 | Grimm et al. | May 2012 | A1 |
| 20120111517 | Borkar et al. | May 2012 | A1 |
| 20120186764 | McKay | Jul 2012 | A1 |
| 20130081771 | Luo et al. | Apr 2013 | A1 |
| 20130133847 | Zhao et al. | May 2013 | A1 |
| 20130139985 | Wright | Jun 2013 | A1 |
| 20130160959 | Rosencrance et al. | Jun 2013 | A1 |
| 20130192782 | Benz et al. | Aug 2013 | A1 |
| 20130306261 | Zhao et al. | Nov 2013 | A1 |
| 20140053996 | Esser et al. | Feb 2014 | A1 |
| 20140060763 | Bode et al. | Mar 2014 | A1 |
| 20140130994 | St. John et al. | May 2014 | A1 |
| 20140182799 | Castro et al. | Jul 2014 | A1 |
| 20140262091 | Lu et al. | Sep 2014 | A1 |
| 20140284011 | Krapsch et al. | Sep 2014 | A1 |
| 20140336314 | Benz et al. | Nov 2014 | A1 |
| 20150020988 | St. John et al. | Jan 2015 | A1 |
| 20150041088 | Castro et al. | Feb 2015 | A1 |
| 20150041089 | Castro et al. | Feb 2015 | A1 |
| 20150041092 | Hietaniemi et al. | Feb 2015 | A1 |
| 20150059998 | Zhao et al. | Mar 2015 | A1 |
| 20150176206 | Chen et al. | Jun 2015 | A1 |
| 20150191875 | Esser et al. | Jul 2015 | A1 |
| 20150197893 | Cheng et al. | Jul 2015 | A1 |
| 20150204019 | Wright | Jul 2015 | A1 |
| 20150299961 | Borkar et al. | Oct 2015 | A1 |
| 20160097160 | Castro | Apr 2016 | A1 |
| 20160097161 | Benz et al. | Apr 2016 | A1 |
| 20160298297 | Borkar | Oct 2016 | A1 |
| 20170328008 | Linder, Jr. | Nov 2017 | A1 |
| 20190031802 | Gu | Jan 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 2176898 | Oct 2006 | CA |
| 4426620 | Feb 1995 | DE |
| 0151994 | Aug 1985 | EP |
| 0183466 | Jun 1986 | EP |
| 0444788 | Sep 1991 | EP |
| 0630909 | Dec 1994 | EP |
| 0657478 | Jun 1995 | EP |
| 1195259 | Apr 2002 | EP |
| 1579071 | Jul 2008 | EP |
| 05-247883 | Sep 1993 | JP |
| H06-299494 | Oct 1994 | JP |
| 2005-001197 | Jan 2005 | JP |
| 2008-049688 | Mar 2008 | JP |
| 2012-107356 | Jun 2012 | JP |
| WO 9705330 | Feb 1997 | WO |
| WO 9710387 | Mar 1997 | WO |
| WO-0000698 | Jan 2000 | WO |
| WO 0011053 | Mar 2000 | WO |
| WO 2004061235 | Jul 2004 | WO |
| WO 2008028865 | Mar 2008 | WO |
| WO 2012007364 | Jan 2012 | WO |
| WO 2014078102 | May 2014 | WO |
| WO-2017197380 | Nov 2017 | WO |
| Entry |
|---|
| Anon, “Daily-use paper project at Fujian HengLi to enter production,” China Pap. Ind. News, vol. 1, No. 13, p. 2 (May 30, 2006). |
| Anon, “An Innovative Approach to Fibre Recovery and Ash, Fines and Colloidals Control for Increased Water System Closure,” TAPPSA Journal, pp. 27-32 (Sep. 2009). |
| Brown, “New Simplified Technology for On-Line Measurement on Tissue Machines,” Process Control News (for the Pulp and Paper Industries), vol. 21, No. 6, pp. 8-9 (Jun. 2001). |
| Devillers et al, “Fines management for tissue machines” International Paperwork (IPW), No. 1-2, pp. 15-18 (Jan.-Feb. 2014). |
| Ecolab Global Knowledge Services, Literature Search Report #10261, 38 pp. (Aug. 21, 2015). |
| European Patent Office, International Search Report in International Patent Application No. PCT/US2017/032616, dated Aug. 7, 2017, 4 pp. |
| European Patent Office, Written Opinion in Internationai Patent Application No. PCT/US2017/032616, dated Aug. 7, 2017, 5 pp. |
| Farley et al., “Sizing With Alkenyl Succinic Anhydridge,” The Sizing of Paper, 2nd Ed., Atlanta, GA: TAPPI Press, pp. 51-62 (1989). |
| Farley et al., “Glyoxalated Polyacrylamide Resin,” Wet-Strength Resins and Their Application, Chapter 3, Atlanta, GA:TAPPI Press, pp. 45-61 (1994). |
| Friberg et al., “Emulsions,” Encyclopedia of Chemical Technology, 41th Ed., vol. 9, pp. 393-413 (Dec. 4, 2000). |
| Gruszka et al., “Testing de-ashing of tissue paper through fractionated de-crilling of selected recycled pulp grades;” Przeglad Pap. (Polish Paper Review), vol. 69, No. 2, pp. 131-138 (2013). |
| Hughson et al. “Characterization of Assessment of Dermal and Inhalable Nickel Exposures in Nickel Production and Primary User Industries,” Ann. Occup. Hyg., vol. 54 , No. 1, pp. 8-22 (2010). |
| Hunkeler et al., “Mechanism, kinetics and modelling of the inverse-microsuspension homopolymerization of acrylamide,” Polymer, vol. 30, No. 1, pp. 127-142 (Jan. 1989). |
| Hunkeler et al., “Mechanism, kinetics and modelling of inverse-micorsuspension polymerization: 2. Copolymerization of acrylamide with quaternary ammonium cationic monomers,” Polymer, vol. 32, No. 14, pp. 2626-2640 (1991). |
| Kraus et al., “Respiratory symptoms and diseases among workers in the soft tissue producing industry,” Occup. Environ. Med., vol. 59, No. 12, pp. 830-835 (2002). |
| Nalco Chemical Company, Hercobond 1000 Product Analysis, 1 pg. (Feb. 25, 2002). |
| Nalco Chemical Company, Parez 631 NC Product Analysis, 20 pp. (Aug. 5, 1999). |
| Panda, “Approaches to high-yield pulping of mechanical pulp types,” Proceedings of the International Workshop on Small Scale Chemical Recovery, High Yield Pulping, and Effluent Treatment, 15 pp. (1991). |
| Peters, “Optimised fibre yield arid stook mixture,” Wochenbl. Papierfabr., vol. 140, No. 7, pp. 545-546 (Jul. 2012). |
| Roy et al., “Effect of Nonfibrous Tissue on the Papermaking Properties of Bagasse and Straws,” IPPTA Convention Issue—Annual General Meeting & Seminar on Non-Wood Fibrous Raw Material Pulping and Paper Making, pp. 49-55 (1993-1994). |
| Sheridan, et al., “Dust—No Longer an Issue for Tissue,” Paper Technology, vol. 46, No. 5, pp. 33-38 (Jun. 2005). |
| Sheridan et al., “Dust—No Longer an Issue for Tissue,” Tissue World 2005 Conference—The 7th International Conference and Exhibition for the Tissue Business—Preprints, 11 pp. (Apr. 2005). |
| Snook, “Non-fibrous Additives to Papermaking Stock,” Handbook for Pulp and Paper Technologies, Chapter 15, pp. 220-227 (1992). |
| Springer et al., “The effect of fibrous fines on tissue properties,” Tappi Journal, vol. 71, No. 2, pp. 99-102 (1988). |
| St. John, “Ondec-Nalco Technical Exchange,” 5 pp. (Jun. 27, 2002). |
| Tatum, “Characterization of Particulate Matter in Workplace Atmospheres of Paper Making and Converting Operations,” NCASI Technical Bulletin, No. 873, 36 pp. (Mar. 2004). |
| Williamson, “Cost-effective automation at SCA,” Paper360, vol. 5, No. 2 pp. 16-17 (Mar.-Apr. 2010). |
| Number | Date | Country | |
|---|---|---|---|
| 20170328008 A1 | Nov 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62336236 | May 2016 | US |
